mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
Irinotecan |
FIMM |
pan-cancer |
AAC |
-0.26 |
0.01 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.02 |